ASC Stock Overview
A health and wellness company, manufactures and distributes healthcare products in South Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Ascendis Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R0.71 |
| 52 Week High | R0.83 |
| 52 Week Low | R0.63 |
| Beta | 0.67 |
| 11 Month Change | -2.74% |
| 3 Month Change | -2.74% |
| 1 Year Change | 2.90% |
| 33 Year Change | -28.28% |
| 5 Year Change | -79.12% |
| Change since IPO | -93.60% |
Recent News & Updates
Shareholder Returns
| ASC | ZA Pharmaceuticals | ZA Market | |
|---|---|---|---|
| 7D | -1.4% | -1.0% | 1.7% |
| 1Y | 2.9% | 0.8% | 15.6% |
Return vs Industry: ASC exceeded the ZA Pharmaceuticals industry which returned 0.8% over the past year.
Return vs Market: ASC underperformed the ZA Market which returned 15.6% over the past year.
Price Volatility
| ASC volatility | |
|---|---|
| ASC Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in ZA Market | 9.5% |
| 10% least volatile stocks in ZA Market | 2.6% |
Stable Share Price: ASC has not had significant price volatility in the past 3 months compared to the ZA market.
Volatility Over Time: ASC's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 14 | A. Neethling | www.ascendishealth.com |
Ascendis Health Limited, a health and wellness company, manufactures and distributes healthcare products in South Africa. It operates through Consumer Health, and Medical Devices segments. The company offers natural supplements, multi-vitamin and mineral supplements, micronutrient supplements, nutraceutical supplements, vitamins, minerals, and homeopathic and herbal products under the Bettaway, Chela-Fer, Chela Preg, Chela Mag, Compounding Pharmacy, Junglevites, Menacal 7, Solal, and Vitaforce brand names.
Ascendis Health Limited Fundamentals Summary
| ASC fundamental statistics | |
|---|---|
| Market cap | R450.54m |
| Earnings (TTM) | R41.57m |
| Revenue (TTM) | R1.47b |
10.7x
P/E Ratio0.3x
P/S RatioIs ASC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASC income statement (TTM) | |
|---|---|
| Revenue | R1.47b |
| Cost of Revenue | R886.86m |
| Gross Profit | R585.18m |
| Other Expenses | R543.61m |
| Earnings | R41.57m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.066 |
| Gross Margin | 39.75% |
| Net Profit Margin | 2.82% |
| Debt/Equity Ratio | 0.8% |
How did ASC perform over the long term?
See historical performance and comparison